SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905718-16-001807
Filing Date
2016-12-15
Accepted
2016-12-15 16:02:10
Documents
2
Period of Report
2016-12-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT mcmahon_form3dec142016.html 3  
1 OWNERSHIP DOCUMENT mcmahon_form3dec142016.xml 3 3273
2 POWER OF ATTORNEY mcmahon_poa.htm EX-24 5160
  Complete submission text file 0000905718-16-001807.txt   10042
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Issuer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address
McMahon Gerald PhD (Reporting) CIK: 0001290747 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-15006 | Film No.: 162053689